share_log

アンジェス---米国で想定以上の臨床試験結果を受け、「コラテジェン(R)」の開発戦略を変更

安捷思——在美国获得超出预期的临床试验结果后,改变了“Collategene(R)” 的开发战略。

Fisco日本 ·  07/24 00:55

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发